The vagus nerve, deeper — afferents, the inflammatory reflex, and the polyvagal debate

The basic portrait of the vagus is familiar: the longest cranial nerve, the parasympathetic "rest and digest" line running from the brainstem to the gut, the thing you are told to "tone" with cold plunges and deep breaths. All of that is true as far as it goes. But it stops well short of the actual physiology, and the actual physiology is stranger and more consequential. To go deeper means following three threads the popular version skips: the direction the nerve mostly carries traffic, the brainstem hub where that traffic arrives, and the reflex by which a nerve regulates the immune system. It also means being honest about a popular theory that has attached itself to the vagus and that many scientists do not accept.

Start with direction, because it overturns the intuitive picture. The word "nerve" tends to summon an image of a command cable running orders outward from the brain. The vagus is almost the opposite. Roughly 80 to 90 percent of its fibers are afferent — they carry information from the body to the brain, not commands from the brain to the body. Only the minority, the remaining tenth to fifth, are efferent motor fibers. This means the vagus is overwhelmingly a sensing apparatus. It is the cable through which the brain learns the state of the heart, the stretch of the lungs, the chemistry of the gut, the distension of the stomach, the presence of nutrients and toxins and inflammatory signals deep in the viscera. The interior of your body is constantly reporting upward, and the vagus carries the bulk of that report. When you feel a vague unease that you cannot name, a calm after a meal, a flutter of nausea before you consciously register a threat, you are often feeling the upward traffic of the vagus shaping perception below the level of awareness. The technical word for this interior sense is interoception, and the vagus is its principal highway.

Where does that traffic arrive? Almost all of it terminates in a small, dense nucleus in the medulla of the brainstem called the nucleus tractus solitarius — the NTS, the solitary nucleus. This is the vagal afferent inbox, and its importance is wildly out of proportion to its size. The NTS receives visceral sensory information not only from the vagus but from taste and from the blood-pressure and blood-chemistry sensors of the cardiovascular system, integrates it, and projects onward to an extraordinary range of targets: the parabrachial nucleus, the hypothalamus, the amygdala, the locus coeruleus that controls brain-wide norepinephrine, and structures governing mood, appetite, and the stress response. The NTS is the relay through which a signal from the gut can reach the circuitry of emotion. It is also the entry point for the antidepressant action of vagus nerve stimulation: stimulate the vagus, drive its afferents into the NTS, and you modulate downstream the very systems — noradrenergic, serotonergic, limbic — that mood disorders involve. The NTS is where "the body talks to the brain" stops being a metaphor and becomes an anatomical address.

Now the efferent minority, because this is where Tracey's discovery lives. The small fraction of vagal fibers that run outward includes the ones that slow the heart, drive gut motility, and stimulate digestive secretion — the classic parasympathetic effects. But it also includes the output arm of what Tracey named the inflammatory reflex, and that reflex deserves to be described in its full mechanical detail, because it is one of the more elegant pieces of physiology discovered in the past few decades. It works as a loop. On the sensory side, vagal afferents detect inflammatory molecules — cytokines like TNF and interleukin-1, or the molecular debris of infection and injury — rising in the tissues, and they report this to the NTS. On the motor side, the brainstem sends signals back down efferent vagal fibers. These fibers communicate with a nerve circuit reaching the spleen, where, through a relay involving the splenic nerve, a specialized population of T cells is prompted to release acetylcholine. That acetylcholine binds a specific receptor — the alpha-7 nicotinic acetylcholine receptor — on macrophages, the immune cells that produce inflammatory cytokines. Binding that receptor tells the macrophage to stop. Cytokine production falls. The nervous system has, in seconds, applied a brake to inflammation.

This is the cholinergic anti-inflammatory pathway, and its conceptual weight is hard to overstate. Before it, inflammation was understood as a fundamentally chemical, locally governed process — cells secreting signals, signals diffusing, other cells responding, the whole thing modulated by drugs that interrupted the chemistry. Tracey's work, built out over years with collaborators at the Feinstein Institutes, established that the inflammatory response is also under fast, direct, hardwired neural control. The brain monitors inflammation through the vagus and can actively suppress it through the vagus. Inflammation became, in part, a reflex — like the knee-jerk, but for the immune system. That reframing did not just add a footnote to immunology; it created a new discipline, bioelectronic medicine, premised on the idea that if a nerve controls a disease process, you might treat the disease by controlling the nerve.

The clinical translation has been real and is worth stating precisely, because the difference between approved and experimental matters. Implanted vagus nerve stimulators have been FDA-approved since 1997 for refractory epilepsy and since 2005 for treatment-resistant depression — these are established, regulated uses, however imperfect the response rates. The inflammatory-reflex application is newer and still largely investigational: SetPoint Medical and others have run trials placing small vagus nerve stimulators in patients with rheumatoid arthritis, and the published results have shown meaningful reductions in disease activity in patients who had exhausted conventional drugs. This is genuine clinical research building directly on Tracey's rats, and it represents an early proof that you can treat a chronic inflammatory disease by stimulating a nerve rather than by flooding the body with a drug. It is not yet routine care, and the consumer "vagus stimulation" gadgets that borrow the language of this research generally have far weaker evidence behind them.

The afferent and efferent threads come together in the one vagal measurement most people have actually encountered: heart rate variability. The vagus applies a continuous, beat-to-beat brake to the heart through its efferent fibers, and that brake tightens and loosens with the breath — the heart speeds slightly on inhalation, slows on exhalation, a pattern called respiratory sinus arrhythmia that is mediated by the vagus. HRV quantifies that variation, and because the variation reflects the vagal brake in action, HRV is the best non-invasive proxy for vagal tone available. Higher HRV generally tracks with cardiovascular health, stress resilience, and, in long-term studies, lower mortality. What reliably raises it is less exotic than the marketing suggests: slow diaphragmatic breathing at roughly five to six breaths per minute has the most consistent evidence, working by exploiting the same respiratory-vagal coupling that produces the variability in the first place. Cold exposure, humming and chanting that vibrate the vagally innervated larynx, regular aerobic exercise, and meditation all have real but more modest support. The mechanism in every case routes back through the same circuitry: the breath and the body feeding signals up through vagal afferents to the NTS, and the brainstem adjusting the efferent brake in return.

And then there is polyvagal theory, which any deeper treatment of the vagus has an obligation to address squarely rather than absorb uncritically. Proposed by the psychophysiologist Stephen Porges in the 1990s, polyvagal theory has become enormously influential in psychotherapy, trauma work, and the wellness world, to the point that for many people "vagus nerve" and "polyvagal" are nearly synonymous. The theory's central claims are evolutionary and anatomical. It holds that mammals possess two distinct vagal systems with different evolutionary origins — an older, unmyelinated "dorsal" vagal pathway that drives immobilization and shutdown responses, and a newer, myelinated "ventral" vagal pathway, unique or special to mammals, that supports calm and social engagement. It links these to a hierarchy of defensive states: social engagement, then fight-or-flight, then dorsal shutdown. The framework has given clinicians and patients a vivid, intuitive vocabulary for states of safety, threat, and collapse, and that clinical usefulness is part of why it spread.

But the theory's specific factual claims are contested by a substantial body of researchers, and the contest is not a minor quibble. Critics — including comparative physiologists like Paul Grossman and Edwin Taylor — have argued that key evolutionary premises do not hold up. The claim that a myelinated, cardio-protective vagal pathway is uniquely mammalian is disputed; myelinated vagal fibers and respiratory-cardiac coupling appear in other vertebrate lineages, complicating the neat evolutionary hierarchy the theory proposes. Critics also argue that the theory conflates respiratory sinus arrhythmia with vagal tone in ways the data do not fully support, and that some of its predictions have not been borne out empirically. The crucial point for a reader is this: the well-established vagal physiology — the afferent dominance, the NTS as integrating hub, the inflammatory reflex, the HRV-vagal-tone relationship — does not depend on polyvagal theory being correct. That physiology stands on its own experimental footing. Polyvagal theory is a separate, broader, and more speculative interpretive framework layered on top of it, and one can accept everything in the first three threads of this article while regarding the specific evolutionary architecture of polyvagal theory as unproven. The honest position is to keep the two separate: take the clinical vocabulary for what it offers patients, but do not mistake a popular framework for settled neuroscience.

What does the deeper view change, practically? Mostly it sharpens what you are actually doing when you "work on your vagus nerve." You are not toning a muscle or charging a battery. You are, on the afferent side, shaping the stream of interior signals reaching the NTS — which is why slow breathing, which changes the pattern of stretch signals from the lungs, has real effects on mood and arousal that are not merely psychological. You are, on the efferent side, exercising and biasing a brake that governs the heart and, through the inflammatory reflex, the tone of the immune system. The vagus is the structural reason that the boundary people draw between "mental" and "physical" is, at the level of the body, mostly fictional. A signal about inflammation in the gut and a signal that becomes a feeling of unease travel the same nerve to the same nucleus. A slow exhale and a quieted immune response share a circuit.

That is the deeper implication. The vagus is not a relaxation hack and not a single switch to flip. It is the physical infrastructure of a two-way conversation between the brain and the body's interior, weighted heavily toward the body's reporting upward, and equipped with a fast neural brake on inflammation that medicine is only beginning to learn how to use. Understanding it at that level makes the basic interventions more credible, not less — and makes the inflated claims, whether from a gadget or from an overextended theory, easier to recognize for what they are.